Stockreport

Apimeds Pharmaceuticals and Lokahi Therapeutics Announce FDA Type C Meeting Scheduled for LT-100 (Apitox)

Apimeds Pharmaceuticals US, Inc.  (APUS) 
PDF MATAWAN, N.J. & LA JOLLA, Calif.--(BUSINESS WIRE)--Apimeds Pharmaceuticals US, Inc. and Lokahi Therapeutics, Inc. today announced that the U.S. Food and Drug Adminis [Read more]